The diagnostic benefits of SLN evaluation include an ability to identify the extent of tumor dissemination and the utility of SLN mapping in guiding targeted adjuvant treatment in high-risk patients.
Jvan Casarin, MD
Advertisement
Articles by Jvan Casarin, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment
2
BI-1808 Earns FDA Fast Track Status for Advanced Ovarian Cancer
3
Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?
4
Bispecific Antibodies for Older Patients With Relapsed/Refractory Multiple Myeloma
5